steve kirsch fluvoxamine

This is quite stunning because the PK of the drug done at the Gates Foundation shows it only reaches 50% of the final concentration after 3 days. Ive talked to doctors who are extremely familiar with the drug and all the trial results and they would prescribe it to their patients. I took it myself at that dosage and noticed zero side effects. We don't know why the NIH panel is ignoring fluvoxamine and we aren't allowed to find out. Then he hosted a superspreader event. The documents in the data room discuss all eight (you'll need access to the restricted area to see the presentation on all 8). How can the FDA say a drug which meets the gold standard of evidence has insufficient evidence? Skirsch.io Steve Kirsch Home page Fluvoxamine, COVID, pandemic, . This is a more comprehensive look at the key evidence supporting fluvoxamine: Hear from the doctors who did the studies directly as well as the Dean of Medicine at Emory University: List of the best evidence-based COVID treatment options. Fluvoxamine works on hospitalized patients too, but no US hospital will let you use it (sound familiar? No more. Steve wanted to say, Look, Ive got all these famous [infectious disease] docs and researchers, and they all say give fluvoxamine a chance, Judith Feinberg, one of the former CETF advisory board members and vice chair of research at the West Virginia University School of Medicine, told me. Do they sell it anywhere? Kirsch told me that meta-analyses are a higher level of evidence than randomized controlled trials. When I responded that meta-analyses are only as good as the data they are based on, he said Id like to understand your source on that, because I cant find a source that says a phase 3 trial is greater evidence than a meta-analysis., When you characterize me, you need to say that Steve Kirsch doesn't go with majority votes on interpreting data.. (Siliciano did not respond to requests for comment for this article.). My favorite dosage is 50mg twice a day for 14 days. I bumped up the reward to $1M. The Wall Street Journal thinks it should be used (and that the NIH is wrong for waiting for more clinical trials). Completely avoid caffeine, alcohol, tylenol, and benadryl. The 50mg BID dose was quite effective, but it has to be started early (as soon as symptoms start). Fluvoxamine is a very safe drug on market for 37 years, tens of millions of people have taken it, no record in scientific literature of anyone dying on overdose, and according to doctors that know the drug the best, about as dangerous as taking a Tylenol. It was 25 years ago yesterday that Andrew Wakefield launched the modern iteration of the antivaccine movement.In doing so, he laid down a template that antivax quacks today still follow. (Clayton Fox, Marty Makary, and Jeffrey Klausner). Im sorry to sound so cynical. Fluvoxamine has a systematic review and meta-analysis published in a top medical journal. I will . Since FLV is a safe drug, it should have been widely discussed with patients that there is virtually no downside and a huge reduction in hospitalization if the drug is given early. . Jeffrey Morris, director of biostatistics at the University of Pennsylvania Perelman School of Medicine, has made debunking Kirschs claims something of a hobby. The drug was widely prescribed as a covid treatment for much of 2020, based on anecdotes and flawed studies. While Fauci was crafting national pandemic policies, Fauci's wife [Christine Grady, Chief Bioethicist, NIH] was back stopping [them]." Report coming soon. The FDA is will take months to deliberate on the fluvoxamine EUA application that we submitted on January 29. Steve Kirsch is a Silicon Valley philanthropist. Some people are jittery, but usually that is because the doctor either prescribed a dosage higher than 50mg twice a day or didnt notify the patient to. Steve Kirsch is an inventor of the optimal mouse, a Silicon Valley millionaire, and an MIT alum (Class of '80). Adverse reactions/side effects. The External Medicine Podcast - Fluvoxamine as a potential treatment for COVID-19: An Interview with Steve Kirsch. ICER Publishes Final Evidence Report and Policy Recommendations on Outpatient Treatments for COVID-19 - ICER. In short, a lot of mumbo jumbo. Its motivated out of his sense of keeping people safe and advancing health care.. Doctors are afraid that even with a 37-year safety record of this drug, that something will go terribly wrong and they will be blamed. He might be a good snake oil salesman., I experienced this myself when, on one call, we discussed several studies. It was completed in August. has tons of info on fluvoxamine with all the links. If you cant lay off the java, then try fluoxetine (Prozac). In May, all 12 members of CETFs scientific advisory board resigned, citing his alarming dangerous claims and erratic behavior. Hes very convincing. While he declined a phone interview, Boulware was recently the subject of a Mother Jones article about the harassment hes received for his research on hydroxychloroquine and ivermectin. Answer (1 of 2): Yes, In a preliminary study of COVID-19 patients with mild-to-moderate disease who were attempting to recover in their homes, researchers at Washington University School of Medicine in St. Louis have found that the drug fluvoxamine seems to prevent some of the most serious compli. In September, Kirsch emailed Morris asking him to estimate the maximum number of deaths caused by vaccines. Instead, the government prefers to fund and promote new, proprietary drugs and vaccines, he says. Timing is everything with respect to outcomes. The babys brain was split in half, and it was just covered with blood. The NIH picks the drug that makes the most money for the drug companies regardless of long-term safety Molnupiravir! I've collected fluvoxamine evidence here for convenient access. The trials that were abandoned for futility werent getting events because the patients were given standard of care meds. (article I did after the TOGETHER trial). So you can address your OCD and if you get COVID, youll can up the dose. He is frequently brash and interruptive, peppering dire warnings about vaccines with veiled aspersions toward Anthony Fauci and vague references to influential people who agree with him in private but cannot speak publicly. All the researchers are convinced the drug works. Jeffrey Glenn, an infectious disease professor at Stanford University, calls the inaction on the current evidence on the table "criminal.". All can merit a fluvoxamine prescription based on traditional diagnoses. Three of the four outpatient trials have been reported out: all were successful. I disagree with his interpretation of the data regarding several medicines and strongly disagree with his anti-vaccine nonsense, Boulware wrote to me. Doctors who have used fluvoxamine in the US and other countries swear by it. One Silicon Valley entrepreneur thought he could beat the odds. 21. and increased heart rate (which could be nerves about the dilated pupils). The repository goes over the prescribing guidelines, contraindications, and describes the effect on caffeine consumption while on drug (basically you want to avoid caffeine while on the drug). reach out to us at The data we have today with just 2 clinical trials (RCT and confirmatory RWE) is compelling. All have had a 100% success record in keeping their patients out of the hospital. You can use fluoxetine as well (aka Prozac). You can use fluoxetine as well (aka Prozac). I didnt intend to spend a lot of time on Steve in particular, but that video was so influential.. If you do have a side-effect, it is usually mild nausea which goes away when you stop taking the drug. There were IRB rules that required the 65 patients to be listed in the diagrams and charts. So much for evidence-based medicine. There are two ways Ive discovered that I may be able to save the world, he told an IEEE Spectrum reporter in 2000. [https://www.quora.com/What-is-the-current-treatment-for-Covid-19/answer/, The most urgent need in the country right now is to reduce. Unfortunately, as Jeffrey Morris at UPenn points out, public health officials and scientists have done plenty to undermine their own authority, like claiming masks dont work, downplaying the natural immunity conveyed by previous covid infections, and not doing enough public communication about vaccine safety surveillance systems. Fluvoxamine is the poster child of the COVID-19 Early Treatment Fund (CETF). There are reports of people who cant tolerate the drug, but they stop using it and nothing bad happened. skirsch.io Steve Kirsch Home page. Kirsch is a serial entrepreneur who has spent decades pitching the next big thing, whether optical mice (Mouse Systems), document processing (FrameMaker), search engines (Infoseek), digital. That was a lie. Weve known it works since August 24, 2020. It works best when it is given early, as soon as symptoms start. This is why Cliff doesnt talk to me. Comparison with molnupiravir. Or just depression about the vaccine mandates? As trial results rolled in, that mismatch began to put a strain on Kirschs relationship with the funds advisory board. Perhaps Kirschs most effective tactic, though, is simply his willingness to outlast everyone else. So probability of successful Phase 3 can be estimated to be over 99.99% since there are tens of thousands of phase 3 studies. He told me that while he and his family got vaccinated as soon as they were eligible, he got the idea that vaccines are dangerous from a man he hired to clean his carpets, who got very sick after receiving the vaccine. Less than a week later, David Seftel read about the Lenze trial, and ignored the JAMA advice. People who report not tolerating the drug are typically prescribed too high a dose. I think we did rigorous reviews of proposals for research.. Have the drug on hand. We could have saved a lot of lives. The U of M's study focused on three common drugs: ivermectin, metformin, and fluvoxamine. Think about it Molnupiravir has a 50% risk reduction whereas fluvxoamine is over 90%. There is an executive summary below, but the most important thing is that top infectious disease docs who have looked at all the evidence (including the two clinical trial results) believe the effect size is 75% or more in reducing the hospitalization rate. Doctors have no excuse for not prescribing. Elsewhere he has said he began questioning vaccine safety after an unnamed Twitter follower told him several family members died after getting their shots. Yeah, its possible, he told mehe also says that he has regularly seen Kirsch manipulate evidence so that it seems to support claims that are, in reality, baseless. Steve calls himself a "medical philanthropist" who says "the most important thing to me is saving lives." In . . The NIH picks the drug that makes the most money for the drug companies regardless of long-term safety Molnupiravir! To scientists, giving fluvoxamine a chance means running a large trialnot giving it to individual patients in the clinic, off-label and outside the context of active data collection and analysis. Months later, the site wont disclose how many doses it helped deliveror what it plans to do with user data. Jan 17. So much for evidence-based medicine. Steve Kirsch. No long haul symptoms if you start the drug ASAP after first symptoms. Fluvoxamine is also an After I ended the Zoom meeting, Satterfield called me to apologize for cutting us off. When you need to characterize me, you need to say that Steve Kirsch doesnt go with majority votes on interpreting data, he told me when I asked about his views on ivermectin, which he insists is a silver bullet against covid. His efforts became more focused on medical research when, in 2007, he was diagnosed with a rare blood cancer. The drugs mechanisms of action were explained to the KOL panel which voted 2>1 in favor of fluvoxamine. Its all about NIH saying it is OK. Medicine today is driven by government opinion, not science. Today, we are letting people drown and we are not even telling them there is a life preserver they can ask for today with compelling evidence that is under consideration by the life preserver safety group. All the medical journals refused to publish the meeting notes (rejected by 6 journals). Part of TV News Archive. I believe they made the right decision and we should be rushing to follow their advice. There are other non-prescription things you should always have on hand. Please, As of November 13, fluvoxamine has been proven to work in every trial that has published results, including, studies. During our first conversation, which turned into a multi-hour Zoom session, Kirsch paced through the rooms of his cavernous house with his phone held at chest level, rarely looking down at the camera. While combining the results of several well-designed trials can strengthen an argument or unearth patterns unseen in smaller samples, a meta-analysis is just the sum of its parts; any single well-done experiment is more useful than combining the results of several poorly done ones. We now have a viable solution to reduce COVID hospitalization and mortality; Say you just got diagnosed with COVID. Its really, really common for a small effect, something that looks exciting, to be a statistical fluke when you look at a larger population. 90,000 Americans will die from COVID in just the next 3 weeks, a third of recovered patients from COVID will return to the hospital within 5 months and 1 in 8 die, Lenze fluvoxamine RCT that was published in JAMA. Author Affiliations Article Information. It is an amazing drug and is a very simple safe way to avoid long-haul COVID symptoms. The paramedics will think you are on drugs. No long haul symptoms if you start the drug ASAP after first symptoms. If you are experiencing any odd adverse reactions, youll need to consult with your doctor ASAP. I learned this the hard way. In three phone conversations, as well as dozens of emails, his responses to questions about claims in this story were imprecise or constantly changing. Fluvoxamine is used commonly to treat obsessive-compulsive disorder (OCD), social anxiety disorder and depression. In November, CETF gave the group an additional $500,000 for a phase 3 clinical trial that might show conclusive proof of efficacy. Drug researchers at Washington University in St. Louis reached out to Kirsch looking for $67,000 to finish a very smallbut placebo-controlledtrial. An MIT Technology Review investigation recently revealed how images of a minor and a tester on the toilet ended up on social media. But while this effort was praiseworthy, Kirsch's predilection for oversimplifying and exaggerating led him to mislead. All this was known back in January 2021 when a key opinion leader panel of experts from NIH, CDC, FDA, academia, and journal editors voted by over 2:1 to recommend that fluvoxamine be recommended to physicians to discuss with patients. Server IP cope with resolved: Yes Http reaction code: 200 Response time: 0.27 sec. Hes a genuinely good guy. There may be a depression of libido while on drug, but since the drug is taken on acute basis, this is only temporary and it reverses once the drug is stopped. You can experience serious side effects if you do not pay attention to interactions such as if you are currently on another SSRI of a different type. Mouse Systems is not a household word, he told the journalist. More recently, hes adopted extremist positions on covid vaccines, which he alleges are toxic. He has claimed that one in 1,000 people who have received mRNA vaccines have died as a result, and even claimed the vaccines kill more people than they save at an FDA public forum, which was first reported by the Daily Beast. Late in the session, minutes before this impromptu video wrap up, Tip o' Spear Steve Kirsch addressed the panel and revealed that the FDA had just shot down Fluvoxamine as an approved COVID treatment. Steve angrily decried this development as more evidence of FDA corruption. Its actually much harder to parse out a signal than if youre treating diabetes or cancer., In addition to the issues with fluvoxamine, advisors grew increasingly uncomfortable with Kirschs posts about ivermectin, which he has repeatedly claimed in blog posts and appearances in alternative media can be used together with fluvoxamine to prevent 100% of covid-19 deaths. He started a covid-19 vaccine company. For decades, coders wrote critical systems in C and C++. Some people report mild nausea while on the drug (stops when stop the drug). Steve Kirsch Executive Director at COVID-19 Early Treatment Fund (2020-present) Author has 176 answers and 1.7M answer views Updated 1 y Both. Thanks for working tirelessly to help others. Independent appraisal committee votes 11-2 that the evidence is not adequate to demonstrate a net health benefit for molnupiravir over symptomatic care alone; Paxlovid and fluvoxamine receive more favorable votes. You see this with people who have a lot of money, who think that reflects their intelligence, Richman told me. . That trial has now been completed, and the researchers are analyzing their data. Los Altos Hills resident Steve Kirsch funded research into the drug fluvoxamine as a treatment for COVID-19. BOMBSHELL: Top biostats professor admits we have NO CLUE # of people KILLED by COVID vaccines, he wrote. So check the side-effects list to be familiar with which side-effects are associated with which drug so if you have a side-effect, youll know which drug to reduce or eliminate. Steve Kirsch -Executive Director at COVID-19 Early Treatment Fund Ivermection study - One .2mg/kg dose a week for prevention "100% success rate whereas those doctors taking placebo had a 59%% infection rate not a typo 237 of 400 docs on placebo got infected vs. 800 docs on Ivermectin none got infected" Antivirals Pretty much nothing changed when the Phase 3 trial confirmed fluvoxamine worked. Skirsch.io traffic volume is 1,957 unique daily visitors and their 3,914 pageviews. They all promised me when fluvoxamine passed Phase 3 trials, nearly everyone would use it. After two weeks (since it was a tight knit community, everyone could see what was happening to the two groups), every track worker who got sick with COVID, demanded the drug. Fluvoxamine, COVID, pandemic, . Every earlier study of fluvoxamine (such as observational studies) showed it work and the mechanism had been shown. Last Checked: 03/03/2023. (The ivermectin data are trash, Feinberg told me. A video presentation by Steve Kirsch, Executive Director of the Covid-19 Early Treatment Fund. 533. Think about it Molnupiravir has a 50% risk reduction whereas fluvxoamine is over 90%. He is the inventor of the optical mouse and one of the first Internet search engines, Infoseek. Its the gold standard of medical evidence. Boulware disputes that, and says that although Kirschs funding was important, his statements about drugs and vaccines have proven problematic. But Kirsch is also motivated by an unsatisfied competitive streak. February 17, 2021. . By Steve Kirsch Last updated: March 14, 2021 After I appeared on the60 Mi nut es story about fluvoxamine,I've received a lot of questions from people about how to treat COVID. Since then, he has continued to promote fluvoxamine, along with ivermectin and hydroxychloroquine. We pretty much practice government agency opinion medicine all over the world now, with just a few exceptions. . As noted before, the repository has a link to the 1 hour serotonin lecture. After publication of the recommendation in December 2021, the NIH did absolutely nothing change their recommendation. Pretty much nothing changed when the Phase 3 trial confirmed fluvoxamine worked. Why the FDA should grant an EUA for fluvoxamine immediately, a brilliant op-ed in the Wall Street Journal, "Too much caution is killing COVID patients. Kirsch and his group received a fresh wave of attention off hopeful trials of the antidepressant fluvoxamine, which ultimately won him a spot on 60 Minutes in March. Those days are gone. and here are the slides I used in, Collections of op-eds and presentations about fluvoxamine, Please see my answer on Quora The 5 observational studies is icing on the cake. In-patient use. In two trials (both published studies in peer reviewed journals with Editor's Choice in both cases), the drug had a 100% effect size in protecting against hospitalization from the respiratory symptoms from COVID. . Dr. Seftel is an NIH-funded researcher and an NIH reviewer. In fact, he was unwittingly the source for one of Kirschs figures. This looks ominous, but it harmless. The track management was so impressed, they asked for prescriptions. And not zero., Kirsch immediately forwarded the exchange to me and, I suspect, other journalists. I fully expected both organizations to do absolutely nothing. You can help by bringing this document to your doctor's attention. It is not unusual to be wary of developing science, or wrong to be skeptical of pharmaceutical companies. With cases spiking, the Los Angeles area banned gatherings. This is what the Seftel trial at Golden Gate fields used. Hes also publicly railed against what he claims is a campaign against drugs like fluvoxamine and ivermectin. of the 'intellectual dark web '" and allowed him to access a "large and receptive audience to his claims about a fluvoxamine conspiracy". Everyone is stunned, but nobody is surprised. This is the gold standard of evidence based medicine, Article about the fluvoxamine rejection (The Verge). There were no studies reported out so far where fluvoxamine made things worse or neutral. Read More fluvoxamine The Fluvoxamine FAQ The WashU Phase 3 study hasnt been disclosed yet, but they had compliance problems with their patients this time around (phase 2 was local so the patients got the drug early and also were very compliant and the placebo group was truly taking nothing). If the drug is started right after symptoms, weve seen 100% prevention in hospitalization. The incident, he added, was completely in keeping with his personality.. NIH doesnt want you to get the drug since it would compete with Molnupiravir, so fluvoxamine will never make the NIH guidelines. He has a history of giving away some of his millions to good causes, and when COVID-19 began. The US government accused Janssen of improperly promoting the antipsychotic drug Risperdal to dementia patients despite the drug increasing deaths in the elderly. Over the last 18 months, the fund has granted at least $4.5 million to researchers testing the covid-fighting powers of drugs that are already FDA-approved for other diseases. including the very promising Fluvoxamine. This should be top news, but the press is ignoring this and attempt to write stories about it are killed by the editors. I also think it makes a lot of sense to look for pre-existing drugs that can help treat covid symptoms. Quick Summary . From the French observational data (see the very last page), it appears that the biggest effect is limiting serotonin release (any SSRI will do that). All the supporting observational studies were positive as well. Paper reviewing the evidence and mechanisms of action for fluvoxamine: Lenze Phase 2 RCT published Nov 12, 2020: Seftel RWE trial that confirmed the Phase 2 trial published Feb 1, 2021. Most recent articles first. They knew in advance it was coming and on the day the paper was published they ignored it entirely. Note: normally I have lots of hyperlinks to all the sources, but Im pressed for time. As of January 18, 2021, the CDC estimates that 90,000 Americans will die from COVID in just the next 3 weeks. iRobot said it had consent to collect this kind of data from inside homesbut participants say otherwise. So check the side-effects list to be familiar with which side-effects are associated with which drug so if you have a side-effect, youll know which drug to reduce or eliminate. One user reported dilated pupils and increased heart rate (which could be nerves about the dilated pupils). The WashU Phase 3 study hasnt been disclosed yet, but they had compliance problems with their patients this time around (phase 2 was local so the patients got the drug early and also were very compliant and the placebo group was truly taking nothing). Sage Hana. Most recent articles first. So why would we wait when lives are being lost? To protect M10 from my COVID-19 vaccination opinions, I will no longer post about my vaccination concerns here. The web value rate of skirsch.io is 2 . . People are dying because of physician fear of a new treatment with a 100% success rate and a solid mechanism of action. Fluvoxamine for COVID-19 summary Steve Kirsch Executive Director COVID-19 Early Treatment Fund stk@treatearly.org 650-279-1008 Google Docs This is a more comprehensive look at the key evidence supporting fluvoxamine: Fluvoxamine for COVID-19 All the medical journals refused to publish the meeting notes (rejected by 6 journals). They were giving covid patients the antidepressant fluvoxamine as soon as possible after diagnosis, based on anecdotes about the drug limiting the runaway immune response that causes many severe symptoms. Keeping this drug off the NIH Guidelines does nothing to reduce the death rate. Fluvoxamine has a 40 year safety track record. Kirsch is a serial entrepreneur who has spent decades pitching the next big thing, whether optical mice (Mouse Systems), document processing (FrameMaker), search engines (Infoseek), digital. In October, the group reported that, while a few patients in the placebo group ended up in the hospital, none of the patients receiving fluvoxamine got sick enough to go. In other cases, stop cold turkey. Here are my answers. We pretty much practice government agency opinion medicine all over the world now, with just a few exceptions. It has enrolled only 130 people in the first month and is enrolling only 70 per week now. Those days are gone. Fluvoxamine at 50mg twice a day for 14 days is a very well-tolerated drug (as long as you avoid caffeine and alcohol) for the treatment of COVID infections. CETF funded David Boulware's trials on hydroxychloroquine and the Phase 2 and Phase 3 fluvoxamine trials, among many other research projects. But an Editor's Note urged physicians to treat this as a hypothesis and not as a basis for clinical decision-making. It cant be more clear than this. The effect size is huge if the drug is given early right after symptoms start. It doesnt get much better than that. Today, if we follow the CDC advice, nearly 100,000 people a month will die from COVID. Other SSRIs work as well, but fluvoxamine activates the Sigma-1 receptor the most of the SSRIs which is why it was chosen. As of November 13, fluvoxamine has been proven to work in every trial that has published results, including outpatient and inpatient studies. . Ive used it personally at 50mg twice a day and experience no adverse events at all. He has been a medical philanthropist for more than 20 years. Kirsch: Yes, but you could easily watch that 60 Minutes story and believe that we need more data before people should start using fluvoxamine. Other drugs in this class include Prozac (fluoxetine), Zoloft (sertraline) and Paxil (paroxetine). Skirsch.io site visitors volume is 1,957 unique day-to-day guests and their 3,914 pageviews. Medicine isnt about saving lives anymore. , a non-profit known as the nations drug pricing watchdog, did a review of the evidence and determined that fluvoxamine evidence is superior to Molnupiravir. Now weve lost the high ground, Morris told me. The reason that it isnt used is because the medical community ignores evidence-based medicine principles. Design thinking was supposed to fix the world. Their willingness to lie did. There is absolutely no evidence that either one of these claims is true, as Morris has carefully documented. He applied the drug to a large COVID outbreak at Golden Gate Fields just days after the Lenze trial was published. That study was featured on 60 Minutes. If you do have a side-effect, it is usually mild nausea which goes away when you stop taking the drug. Over the summer, the conflict reached his most recent startup, M10. 707. They left their recommendation of fluvoxamine at NEUTRAL. The medical community did nothing (with a few exceptions like Dr. Seftel). Note that some of these articles are inaccurate. The alarming article cited the claims of two anti-vaxxers, Steve Kirsch and Dr. Robert Malone. The. P-value was 10^-14 on that study (done by Dr. In June, after CETFs advisory board resigned, Kirsch did a Facebook Live video with Zelenko and celebrity rehab coach Dr. Drew. He wrote on his personal website that hed been advised that being associated with the drug would immediately trash my credibility.. Seftel used a 50mg BID dosing for 14 days which was one third of the max dose used in the Lenze study. Fluvoxamine was reportedly added to just 2 practice guidelines (Ontario and Johns Hopkins). This is what the Seftel trial at Golden Gate fields used. If there is a better drug on the table today than fluvoxamine, the NIH panel should put that one on the guidelines. If you start later, doctors use higher dosages and compliance becomes a bigger problem. What's even worse is that a third of recovered patients from COVID will return to the hospital within 5 months and 1 in 8 die. It could do nothing. Why fluvoxamine isnt used. The premise made sense: Most experts were predicting vaccines would take years, while finding helpful drugs with known safety profiles could shortcut the approval process. 1991-1992 to 7.1% in 2001-2002. At the dosing for COVID (50mg BID x 14 days), there is a 1% chance of mild-nausea and because the dose is so low and the time it is taken is so short, and there are no psychotropic effects (which require more than 3 weeks of use; the psychotropic effects non-existent if you don't have depression or an anxiety disorder in the first place). Personal life. 1. Medicine today isnt about saving your life. How can we get fluvoxamine?

Eastbourne Airshow Crash, Volusia County Sheriff Daily Activity Report, Do Rabbits Have Cheek Pouches, Articles S